title: Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens.
authors.affiliation: Department of Hematology and Medical Oncology, Georg August University, Goettingen, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Hohloch
authors.affiliation: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Zeynalova
authors.affiliation: Department of Internal Medicine I, University of Saarland, Saar, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Held
authors.affiliation: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Ziepert
authors.affiliation: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Loeffler
authors.affiliation: Department of Hematology and Medical Oncology, Georg August University, Goettingen, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Wulf
authors.affiliation: Department of Hematology and Stem Cell Transplantation, St Georg Asklepios Hospital, Hamburg, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Schmitz
authors.affiliation: Department of Internal Medicine I, University of Saarland, Saar, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Pfreundschuh
authors.affiliation: Department of Hematology and Medical Oncology, Georg August University, Goettingen, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Trümper
mesh_terms: D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D016016:Proportional Hazards Models; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone